Life sciences
Our dedicated life sciences solicitors and patent litigators bring deep technical knowledge in chemistry, biochemistry, biotechnology, physics, engineering, pharmaceuticals, and digital health. Recognised as one of the leading life sciences law firms, Bristows advises organisations of all sizes across the global life sciences industry.
How our life sciences lawyers can help
At Bristows, our dedicated team of over 90 life sciences solicitors and patent attorneys supports organisations across the global life sciences industry. Recognised as one of the UK’s leading life sciences law firms, we provide specialist advice on:
- Intellectual property in life sciences, including patents, trademarks, and licensing
- Regulatory matters such as approvals, labelling, and compliance
- Competition and transactional law across mergers, acquisitions, and collaborations
- Dispute resolution and life sciences patent litigation
- Data protection and ESG in life sciences
Our lawyers combine deep legal expertise with strong technical backgrounds in disciplines such as biology, chemistry, biotechnology, physics, and engineering. This blend allows us to advise on cutting-edge innovations, from pharmaceuticals and biotech to medical devices, digital health, and nanotechnology.
We work with a broad client base that includes pharmaceutical companies, medtech innovators, biotech start-ups, specialist investors, universities, and government bodies. By drawing on diverse perspectives and a fully integrated practice, we provide clear, commercially focused advice that helps clients navigate today’s challenges while preparing for the future of life sciences.
Recognised as a leading life sciences law firm
Life Sciences: IP/Patent Litigation - Band 1
Life Sciences: Regulatory – Band 2
Life Sciences (Europe)
Life Sciences & Pharmaceutical Sector (International & Cross-Border) (UK)
Life Sciences: Transactional - Band 2
Life Sciences and Healthcare - Tier 1
Life Sciences: Transactional – Band 2
Life Sciences (Europe wide)
Life Sciences & Pharmaceutical Sector (International & Cross-Border)
Life Sciences (Europe wide)
Related topics:
Artificial intelligence | Cell & Gene Therapies | Devices & Healthtech | Digital health | Pharma & Biotech | Life sciences regulatory
Life sciences expert series
Session one:
Claire Phipps-Jones, Louisa Jacobs and Jamie Hatzel explore the science behind ADCs and radiopharmaceuticals, and examine the legal considerations relevant to these technologies.
Session two:
Louisa Jacobs, Erik Müürsepp and Katie Cambrook delve into the science behind oncolytic viruses and therapeutic cancer vaccines, exploring their mechanisms and applications, along with some legal considerations relevant to these technologies.